Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marta Gallach is active.

Publication


Featured researches published by Marta Gallach.


The American Journal of Gastroenterology | 2011

Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression.

Jordi Sánchez-Delgado; Emili Gené; David Suarez; Pilar García-Iglesias; Enric Brullet; Marta Gallach; Faust Feu; Javier P. Gisbert; Xavier Calvet

OBJECTIVES:It has been suggested that prevalence of Helicobacter pylori (Hp) in peptic ulcer bleeding (PUB) is lower than that in non-complicated ulcers. As Hp infection is elusive in PUB, we hypothesized that this low prevalence could be related to an insufficiently intensive search for the bacteria. The aim of the study was to evaluate whether the prevalence of Hp in PUB depends on the diagnostic methods used in a given study.METHODS:A systematic review was performed of studies assessing the prevalence of Hp infection in patients with PUB. Data were extracted in duplicate. Univariate and multivariate random-effects meta-regression analyses were performed to determine the factors that explained the differences in Hp prevalence between studies.RESULTS:The review retrieved 71 articles, including 8,496 patients. The mean prevalence of Hp infection in PUB was 72%. The meta-regression analysis showed that the most significant variables associated with a high prevalence of Hp infection were the use of a diagnostic test delayed until at least 4 weeks after the PUB episode—odds ratio: 2.08, 95% confidence interval: 1.10–3.93, P=0.024—and a lower mean age of patients—odds ratio: 0.95 per additional year, 95% confidence interval: 0.92–0.99, P=0.008.CONCLUSIONS:Studies that performed a delayed test and those including younger patients found a higher prevalence of Hp, approaching that recorded in cases of non-bleeding ulcers. These results suggest that the low prevalence of Hp infection described in PUB may be related to the methodology of the studies and to patients’ characteristics, and that the true prevalence of Hp in PUB is still to be determined. Our data also support the recent recommendations of the International Consensus on Non-Variceal Upper Gastrointestinal Bleeding regarding the performance of a delayed diagnostic test when Hp tests carried out during the acute PUB episode are negative.Am J Gastroenterol advance online publication, 8 February 2011; doi:10.1038/ajg.2011.2


Alimentary Pharmacology & Therapeutics | 2011

Meta‐analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer

Pilar García-Iglesias; Albert Villoria; David Suarez; Enric Brullet; Marta Gallach; Faust Feu; Javier P. Gisbert; Alan N. Barkun; Xavier Calvet

Aliment Pharmacol Ther 2011; 34: 888–900


PLOS ONE | 2011

Real-Time PCR Improves Helicobacter pylori Detection in Patients with Peptic Ulcer Bleeding

María José Ramírez-Lázaro; Sergio Lario; Alex Casalots; Esther Sanfeliu; Loreto Boix; Pilar García-Iglesias; Jordi Sánchez-Delgado; Antònia Montserrat; Maria Rosa Bella-Cueto; Marta Gallach; Isabel Sanfeliu; Ferran Segura; Xavier Calvet

Background and Aims Histological and rapid urease tests to detect H. pylori in biopsy specimens obtained during peptic ulcer bleeding episodes (PUB) often produce false-negative results. We aimed to examine whether immunohistochemistry and real-time PCR can improve the sensitivity of these biopsies. Patients and Methods We selected 52 histology-negative formalin-fixed paraffin-embedded biopsy specimens obtained during PUB episodes. Additional tests showed 10 were true negatives and 42 were false negatives. We also selected 17 histology-positive biopsy specimens obtained during PUB to use as controls. We performed immunohistochemistry staining and real-time PCR for 16S rRNA, ureA, and 23S rRNA for H. pylori genes on all specimens. Results All controls were positive for H. pylori on all PCR assays and immunohistochemical staining. Regarding the 52 initially negative biopsies, all PCR tests were significantly more sensitive than immunohistochemical staining (p<0.01). Sensitivity and specificity were 55% and 80% for 16S rRNA PCR, 43% and 90% for ureA PCR, 41% and 80% for 23S rRNA PCR, and 7% and 100% for immunohistochemical staining, respectively. Combined analysis of PCR assays for two genes were significantly more sensitive than ureA or 23S rRNA PCR tests alone (p<0.05) and marginally better than 16S rRNA PCR alone. The best combination was 16S rRNA+ureA, with a sensitivity of 64% and a specificity of 80%. Conclusions Real-time PCR improves the detection of H. pylori infection in histology-negative formalin-fixed paraffin-embedded biopsy samples obtained during PUB episodes. The low reported prevalence of H. pylori in PUB may be due to the failure of conventional tests to detect infection.


Helicobacter | 2010

Accuracy of Monoclonal Stool Tests for Determining Cure of Helicobacter pylori Infection After Treatment

Xavier Calvet; Sergio Lario; María José Ramírez-Lázaro; Antonia Montserrat; Mariela Quesada; Lynsey Reeves; Helen Masters; David Suárez-Lamas; Marta Gallach; Mireia Miquel; Eva Martinez-Bauer; Isabel Sanfeliu; Ferran Segura

Background:  Studies comparing new monoclonal fecal tests for evaluating cure of Helicobacter pylori infection after treatment are scarce. The objective was to compare the diagnostic accuracy of three monoclonal stool tests: two rapid in‐office tools –RAPID Hp StAR and ImmunoCard STAT! HpSA – and an EIA test – Amplified IDEIA Hp StAR.


Gastroenterología y Hepatología | 2013

Manejo de la hemorragia digestiva baja aguda: documento de posicionamiento de la Societat Catalana de Digestologia

Jordi Guardiola; Pilar García-Iglesias; Francisco Rodriguez-Moranta; Enric Brullet; Joan Saló; Esther Alba; Eloi Espin; Marta Gallach; Emili Gené; Llúcia Titó; Faust Feu; Càndid Villanueva; Esther Fort; Francisco José Martínez-Cerezo; Montse Planella; Verònica Pons; Xavier Calvet

Jordi Guardiola , Pilar García-Iglesias, Francisco Rodríguez-Moranta , Enric Brullet, Joan Salo, Esther Alba , Eloi Espin , Marta Gallach, Emili Gené, Llucia Titó, Faust Feu, Càndid Villanueva, Esther Fort, Francisco José Martínez-Cerezo, Montse Planella, Verònica Pons, Xavier Calvet y con el soporte de la Societat Catalana de Medicina d’Urgències i Emergències y el Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III


PLOS ONE | 2011

Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent.

Julio Ponce; Xavier Calvet; Marta Gallach; Marta Ponce

Background Few data are available on the prevalence of erosive and severe esophagitis in Western countries. Objective To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of endoscopies in Spain. Design Retrospective observational study. A multivariate analysis was performed to determine variables predicting severe esophagitis. Setting Databases of 29 Spanish endoscopy units. Patients Patients submitted to a diagnostic endoscopy during the year 2005. Interventions Retrospective review of the databases. Main Outcome Measurements Esophagitis severity (graded according to the Los Angeles classification) and associated endoscopic findings. Results Esophagitis was observed in 8.7% of the 93,699 endoscopies reviewed. Severe esophagitis (LA grade C or D) accounted for 22.5% of cases of the disease and was found in 1.9% of all endoscopies. Incidences of esophagitis and those of severe esophagitis were 86.2 and 18.7 cases per 100,000 inhabitants per year respectively. Male sex (OR 1.89) and advanced age (OR 4.2 for patients in the fourth age quartile) were the only variables associated with severe esophagitis. Associated peptic ulcer was present in 8.8% of cases. Limitations Retrospective study, no data on individual proton pump inhibitors use. Conclusions Severe esophagitis is an infrequent finding in Spain. It occurs predominantly in males and in older individuals. Peptic ulcer disease is frequently associated with erosive esophagitis.


Gastroenterología y Hepatología | 2008

Resultados del tratamiento con interferón pegilado y ribavirina para la hepatitis crónica por el virus C en la práctica clínica. Experiencia de 5 años

Mercedes Vergara; Marta Gallach; Blai Dalmau; Montserrat Gil; Mireia Miquel; Núria Rudi; Antoni Gavarro; Alba Cebollero; Montserrat Masip; Jordi Real


Emergencias | 2013

Guía práctica para el manejo de la hemorragia digestiva alta no varicosa

Marta Gallach; Xavier Calvet; Angel Lanas; Faust Feu; Julio Ponce; Javier P. Gisbert; Enric Brullet; Pascual Piñera; Manuel Castro; Carlos Martín de Argila; Enrique Domínguez Muñoz; Pedro Almela; Cándido Villanueva; Ángel González Galilea; Angel Pérez Aisa; Pilar García-Iglesias; Emili Gené; Albert Villoria; Alan N. Barkun


Gastroenterología y Hepatología | 2009

JUICIO CLINICO FRENTE MODELOS MATEMÁTICOS EN LA PREDICCIÓN DE RECIDIVA Y MORTALIDAD POR ULCERA PÉPTICA SANGRANTE. RESULTADOS PRELIMINARES DE UN ESUDIO PROSPECTIVO MULTICÉNTRICO

Enric Brullet; Xavier Calvet; Rafel Campo; Michel Papo; Montserrat Planella; Félix Junquera; Pilar García-Iglesias; Silvia Montoliu; Albert Pardo; Rl. Ballester; Mireia Miquel; V. Puig Diví; Eva Martinez-Bauer; Albert Villoria; Marta Gallach; Meritxell Casas; Mercedes Vergara


Annals of Hepatology | 2016

Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C.

Marta Gallach; Mercedes Vergara; Mireia Miquel; Meritxell Casas; Jordi Sánchez-Delgado; Blai Dalmau; Montserrat Gil; Núria Rudi; Isabel Parra; María José Bosque López; Angelina Dosal; Laura Moreno; Oliver Valero; Xavier Calvet

Collaboration


Dive into the Marta Gallach's collaboration.

Top Co-Authors

Avatar

Xavier Calvet

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mireia Miquel

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Pilar García-Iglesias

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Mercedes Vergara

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Albert Villoria

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Emili Gené

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Faust Feu

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Julio Ponce

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Blai Dalmau

Autonomous University of Barcelona

View shared research outputs
Researchain Logo
Decentralizing Knowledge